Journals / Anadolu Psikiyatri Dergisi / 2016 / Cilt: 17 - Sayı: 0

Risperidon kullanımına bağlı alopesi gelişen bir olgu

A case with alopecia related to risperidone use

Pages
55–57
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Alopecia which may be seen rarely, was observed in our patient with schizoaffective disorder, thus in this report the patient’s followup, treatment process and approach to alopecia cases were described. (Anatolian Journal of Psychiatry 2016; 17(Suppl.3):55-57)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alopecia involves the loss of some or all of the hair from the head and sometimes other parts of body.
📊
Key Findings & Data:The etiology contains a lot of factors including drug use and psychotropic agents at sometimes.
💡
Conclusion & Impact:Alopecia which may be seen rarely, was observed in our patient with schizoaffective disorder, thus in this report the patient’s followup, treatment process and approach to alopecia cases were described. (Anatolian Journal of Psychiatry 2016; 17(Suppl.3):55-57)
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Alopecia involves the loss of some or all of the hair from the head and sometimes other parts of body. The etiology contains a lot of factors including drug use and psychotropic agents at sometimes. New generationl antipsychotics are less frequently accused, compared to the other psychotropic agents. In the literature, olanzapine, risperidone, ziprasidone, loxapine, quetiapine and haloperidol are the reported drugs associated with alopecia. Alopecia which may be seen rarely, was observed in our patient with schizoaffective disorder, thus in this report the patient’s followup, treatment process and approach to alopecia cases were described. (Anatolian Journal of Psychiatry 2016; 17(Suppl.3):55-57)

Özet

Alopesi, saçlı deride ve bazen bedenin diğer bölümlerinde kısmi veya tam saç kaybıdır. Etiyolojisinde çok sayıda etkenin yanında ilaç kullanımı ve bazı psikotrop ajanların etkisi de bildirilmiştir. Alopesiye neden olabilen psikotrop ajanların içinde yeni kuşak antipsikotikler diğer gruplara göre daha seyrek görülmektedir. Literatürde sıklıkla olanzapin, risperidon, ziprasidon, loksapin, ketiyapin ve haloperidol ile alopesi olguları bildirilmiştir. Şizoaffektif bozukluk tanısıyla izlenen olgumuzda risperidona bağlı alopesi gözlenmiş, nadir görülen bir yan etki olması nedeniyle olgunun izleme ve tedavi süreci ve alopesi olgularına yaklaşım anlatılmıştır. (Anadolu Psikiyatri Derg 2016; 17(3):55-57)

🔖

Cite This Article

KARABULUT, S., ÇAKIR, S. (2016). Risperidon kullanımına bağlı alopesi gelişen bir olgu. Anadolu Psikiyatri Dergisi, Cilt: 17 - Sayı: 0, 55–57. https://ajindex.com/articles/209585

References (16)

  1. Mercke Y, Sheng H, Khan T, Lippmann S. Hair Loss in Psychopharmacology. Ann Clin Psychiatry 2000; 12:35-42
  2. Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother 1999; 33:63-67
  3. Brodin M. Drug-related alopecia. Dermatol Clin 1987; 5:571-579
  4. Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1999; 60:714-725
  5. Leung M, Wrixon K, Remick RA. Olanzapineinduced hair loss. Can J Psychiatry 2002; 47:891- 892
  6. Warnock JK. Psychotropic medications and drugrelated alopecia. Psychosomatics 1991; 32:149- 152
  7. Rook A, Dawber R. Diseases of the Hair and Scalp. Second ed., Oxford: Blackwell, 1982
  8. Dunagin WG. Clinical toxicity of chemotherapeutic agents: Dermatological toxicity. Semin Oncol 1982; 9:14-22
  9. Kubota T, Ishikura T, Jibiki I. Alopecia areata associated with haloperidol. Jpn J Psychiatry Neurol 1994; 48:579-581
  10. Kuloğlu M, Atmaca M, Geçici Ö, Tezcan E. Lityum kullanımına bağlı yaygın saç dökülmesi: Bir olgu sunumu. Klinik Psikofarmakoloji Bülteni 2000; 10:43-46
  11. McLean RM, Harrison-Woolrych M. Alopecia associated with quetiapine. Int Clin Psychopharmacol 2007; 22:117-119
  12. Medical Economics. Physician’s Desk Reference. Ffifty fifth ed., Montvale (NJ): Medical Economics, 2001
  13. MacMorran WS, Krahn LE. Adverse cutaneous reactions to psychotropic drugs. Psychosomatics 1997; 38:413-422
  14. McKinney PA, Finkenbine RD, DeVane CL. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 1996; 8:183-185
  15. Yücel A, Karakuş G, Günaştı S. Psikotrop ilaçların dermatolojik yan etkileri ve tedavi yaklaşımları. Klinik Psikofarmakoloji Bülteni 2008; 18:235-244
  16. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005; 331:951-953.